The Department of Health – Abu Dhabi (DoH), in partnership with the Authority of Social Contribution - Ma’an, has awarded over AED19 million in grants to support advancements in groundbreaking fields such as cell and gene therapies, precision medicine, and advanced cancer treatments.
The Department awarded funding to 11 recipients, including academics, healthcare professionals, and innovators, to support their research and innovation projects under DoH’s Research and Innovation Centre. They're recognised for addressing critical healthcare challenges and advancing patient care.
The grant recipients are focused on advancing cancer research, leveraging technology and improving chronic disease management, by offering solutions such as virtual reality for breast cancer survivors, paediatric metabolic health, precision medicine, and treatments for inherited eye diseases. These diverse initiatives reinforce the transformative potential of medical research in solving pressing healthcare issues.
The accomplishment follows the recognition garnered during the inaugural Abu Dhabi Global Healthcare Week 2024, highlighting the close partnership between DoH, Ma’an, and key community supporters with the mutual goal of enhancing the safety and well-being of Abu Dhabi’s community and beyond.
Dr. Asma Al Mannaei, Executive Director of the Health Life Sciences Sector at DoH, said, “Research funding is the foundation of progress, enabling innovators to turn ideas into life-changing solutions. These grants empower innovators to develop transformative solutions, improve patient outcomes, and reinforce Abu Dhabi’s position as a global healthcare leader.
"By investing in research, we are building a healthcare ecosystem that is proactive, adaptive, and compassionate, designed to meet the needs of our community while shaping the future of healthcare globally. We are proud to recognise and support these visionaries as they pave the way for a healthier future.”
The grants, awarded at the inaugural DoH Research and Innovation Summit, are part of DoH’s strategy to transform the regional healthcare sector through science, technology, and community collaboration.
The summit brought together 200 researchers, innovators, investors, and policymakers to foster partnerships and create a thriving ecosystem for healthcare innovation.
The meeting attracted international participants, including entrepreneurs and scientists. The keynote lecture on Cell and Gene Therapy was delivered by Prof. Waseem Qasim from University College London, UK - a global leader in the field of gene editing and stem cell research.
Panel discussions explored the research and development ecosystem in the UAE, highlighting the opportunities and challenges of conducting clinical trials in the region. These discussions brought together experts from both industry and academia, fostering collaboration to advance cutting-edge research in Abu Dhabi and beyond.